| Financial Ratios | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Return on Equity | -76.915 | 4,861.926 |
| Net Profit Margin | -600.111 | -182.816 |
| Debt to Asset Ratio | 52.491 | 100.465 |
| Cash Ratio | 163.528 | 41.654 |
| Quick Ratio | 178.127 | 55.008 |
| Current Ratio | 182.178 | 59.726 |
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)